They've Done It 20+ Times-Now They've Found a New Memecoin to Watch
Our analysts have built one of the most reliable track records in the memecoin space by recognizing early momentum signals many traders overlook. Their newest pick shows several of the same early indicators found in past standout performers. Get the details before this story spreads.
Shares Stats
| Shares Outstanding | 1,767,350,000 |
| Shares Float | 1,765,740,000 |
| Shares Short | 18,720,000 |
| Insider Holdings | 11% |
| Institution Holdings | 75.17% |
About Abbvie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
General
| Name | Abbvie Inc |
| Ticker | ABBV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 55,000 |
Highlights
| Analyst Target | 249.11 |
| Market Cap | 406,922,700,000 |
| PE Ratio | 173.73 |
| PEG Ratio | 0.41 |
| EBITDA | 29,518,999,552 |
Financials
| Curr Year EPS Estimate | 10.64 |
| Next Quarter EPS Estimate | 3.34 |
| Profit Margin | 3.94% |
| Operating Margin | 31.95 |
| Return on Assets | 0.10 |
| Return on Equity | 1.38 |
| Revenue | 59.6B |
| Earnings Per Share | 1.31 |
| Revenue Per Share | 33.72 |
| Gross Profit | 42,622,001,152 |
| Quarterly Revenue Growth | 0.09 |
Valuation
| Trailing PE | 175.76 |
| Forward PE | 16.39 |
| Price/Sales (Trailing 12 Mt.) | 6.82 |
| Price/Book (Most Recent Quarter) | 50.46 |
Dividend
Abbvie Inc pays out a dividend of $6.50 per share, with a dividend yield of 2.83%.
ABBV's next dividend payment will be made to shareholders on February 17, 2026.
They pay out 263.15% of their earnings out as a dividend.
Recent Dividends
| Feb 17, 2026 | $1.73 |
| Nov 14, 2025 | $1.64 |
| Aug 15, 2025 | $1.64 |
| May 15, 2025 | $1.64 |
| Feb 14, 2025 | $1.64 |
| Nov 15, 2024 | $1.55 |
| Aug 15, 2024 | $1.55 |
| May 15, 2024 | $1.55 |
| Feb 15, 2024 | $1.55 |
Marjorie Taylor Greene Goes Bargain Shopping, Discloses Buying These Two Stocks At 52-Week Lows
Congresswoman Marjorie Taylor Greene disclosed some new stocks recently. Unlike past trades in 2024 and 2025, the latest disclosure is rather unique.
Rahm Emanuel Urges Democrats To Get Tougher on Crime
Rahm Emanuel is urging Democrats to adopt a tougher, community-focused crime strategy as he weighs a potential 2028 presidential run.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Joan Branson, wife of British billionaire Richard Branson, dies at 80
Joan Branson, the wife of British billionaire Richard Branson, has died at age 80.
Trump-Pardoned Ponzi Schemer Faces 37-Year Sentence For $44 Million COVID Scam
A previously convicted Ponzi schemer who had received a pardon from President Trump is heading back to prison due to involvement in a new fraudulent scheme.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
AT&T reached a $177M data breach settlement. What consumers should know about claiming their money
NEW YORK (AP) — AT&T has reached a combined $177 million settlement over two . And impacted consumers have a little over a month left to file a claim for their chunk of the money.
Trump commutes prison sentence for former private equity executive David Gentile
HALLANDALE BEACH, Fla. (AP) — President has commuted the prison sentence of former investment manager David Gentile, who was convicted of defrauding investors — the latest in a Trump has taken in .
The Repeatable Strategy Behind 20+ Early Memecoin Wins (Revealed) - Ad
Few analysts have been able to consistently spot strong memecoin setups, but our team has developed a repeatable framework that has helped them identify high-momentum plays early. Now they've uncovered a new project showing similar characteristics, and they want you to see the full breakdown yourself.
Nvidia, Dell, Coinbase, Gorilla Technology And Archer Aviation: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed lower on Monday, with the Dow slipping 1.2% to 46,590.24, the S&P 500 easing 0.92% to 6,672.41, and the Nasdaq dipping 0.84% to 22,708.07. These are the top stocks that gained the attention of retail traders and investors through the day:
New York advances casinos at a Bronx golf course and near Mets stadium
NEW YORK (AP) — Casinos proposed for a golf course in the Bronx and next to the New York Mets’ ballpark are poised to cash in on a for the New York City area.
Utility Over Hype: ETF Launch Alert - Ad
This ETF isn't about speculation, it's about infrastructure. Seconds-level settlement, low fees, and institutional custody.
Barrick's Breakup Rumors, North America Versus The World
Barrick Mining (NYSE: B) may split into two companies, one focused on North America and another on Africa and Asia.
What to know about the apartment tower fire in Hong Kong
HONG KONG (AP) — Hong Kong firefighters were making a final push to try and find any survivors from the city's , going apartment-to-apartment in the high-rise complex in an exhaustive search.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Trump 'Very Seriously' Considering Australian Retirement Savings System For US Working People: 'It's A Good Plan'
President Donald Trump has revealed that his administration is actively exploring the possibility of implementing a retirement savings system similar to Australia's in the United States.
US air travelers without REAL IDs will be charged a $45 fee
Air travelers in the U.S. without a will be charged a $45 fee beginning in February, the Transportation Security Administration announced Monday.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Why Is Sigma Lithium Stock Gaining Friday?
Sigma Lithium posts Q3 revenue of $28.5M, EPS loss narrows to 10 cents, as sales volumes rise 21% and lithium prices jump 33% Q/Q.
Tim Cook's Potential Successor, China's iPhone 17 Demand And More: This Week In Appleverse
Apple saw major shifts this week, from leadership speculation to streaming moves and a strong iPhone 17 surge in China.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Venmo users have trouble sending and receiving money amid service outage
Users of the payment app Venmo experienced trouble sending and receiving money on Wednesday amid widespread social media posts about service issues.
Cipher Mining Stock Pops As JPMorgan Moves To Overweight
Cipher Mining shares are rising Monday after JPMorgan upgraded the stock to Overweight and raised its price target to $18.
The Next ETF Era Begins with Payments - Ad
After Solana and Hedera, another digital-asset ETF has arrived and it targets global money movement.
Eric Trump Lauds Bitcoin: 'Send $500 Million On A Sunday Night, Virtually No Fees'
Eric Trump has doubled down on his pro-crypto stance, promoting Bitcoin (CRYPTO: BTC) as a fix for inefficiencies in traditional finance and calling i
Meta Allegedly Concealed Evidence Of Social Media Harm, According To Court Filings: Report
Meta Platforms Inc. allegedly hid evidence of social media harm by shutting down a study on Facebook and Instagram's impact on mental health.
D.C.'s Quiet Plan for a New Tech Era - Ad
Why did federal agencies receive orders to "clear the runway" for a phenomenon most Americans haven't even heard of yet? And why are billionaires rushing in weeks before January 1? Whitney Tilson decoded the pattern.
AP Business News Digest
Here are the AP's top business stories that have moved or are planned to move today. All times U.S. Eastern. For up-to-the minute information on AP's coverage, visit AP Newsroom’s .
BellRing Brands: No Ringing The Bell On This One, Not Yet
Our analysis uncovers the real reason behind BellRing Brands' steep fall and why the stock may struggle for much longer.
They've Done It 20+ Times-Now They've Found a New Memecoin to Watch - Ad
Our analysts have built one of the most reliable track records in the memecoin space by recognizing early momentum signals many traders overlook. Their newest pick shows several of the same early indicators found in past standout performers. Get the details before this story spreads.
Trump's $2,000 Tariff Checks Gain Steam As Sen. Katie Britt Says Senate Should 'Take A Look' Amid Soaring 18% Consumer Tariff Burden
Momentum building for Trump's push for $2,000 tariff-funded payments as GOP lawmakers express openness. Treasury Sec. suggests income limits.
Trump Hints At Tax Cut, John Bolton Warns Of Peace Prize Ambitions And More: This Week in Politics
Trump hints at major income tax cuts, while political tensions rise over military orders, Russia policy, and government shutdown threats.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
For conservative media, New York City Mayor-elect Zohran Mamdani quickly becomes attack target
New York City's incoming mayor, Zohran Mamdani, hasn't taken office yet. But he's already the new avatar of evil for conservative media figures.
IRS boosts contribution limits for 401(k) retirement plan savers
Americans will be allowed to contribute more of their money to 401(k) and similar retirement saving plans next year.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Weekend Crypto Roundup: Bitcoin's Scarcity, Dogecoin's Resistance, Tether's Rating, Trump's Crypto Ties And Peter Schiff's Warning
From Bitcoin's scarcity debate to Dogecoin's resistance level, the crypto market was buzzing with activity this past week.
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
Sarepta Therapeutics shares jumped after the FDA issued a new boxed warning for Elevidys.
The Repeatable Strategy Behind 20+ Early Memecoin Wins (Revealed) - Ad
Few analysts have been able to consistently spot strong memecoin setups, but our team has developed a repeatable framework that has helped them identify high-momentum plays early. Now they've uncovered a new project showing similar characteristics, and they want you to see the full breakdown yourself.
S&P Calls Tether 'Weak' — Meanwhile It's Buying More Gold Than Central Banks
Tether (CRYPTO: USDT) just got slapped with the lowest possible stability score from S&P G
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.